Nautilus Biotechnology In...

NASDAQ: NAUT · Real-Time Price · USD
0.71
-0.01 (-1.63%)
At close: Aug 15, 2025, 3:59 PM
0.71
-0.18%
After-hours: Aug 15, 2025, 04:32 PM EDT

Nautilus Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a 8.21M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a 1.61M 1.6M 1.59M 1.59M 1.51M 1.42M 1.17M 921K n/a 829K 806K 263K n/a 300K n/a
Gross Profit
n/a n/a n/a -1.61M -1.6M -1.59M -1.59M -1.51M -1.42M -1.17M -921K n/a -829K -806K -263K -277K -300K n/a
Operating Income
18.84M -18.84M -19.98M -19.1M -20.79M -21.61M -20M -19.07M -19.02M -18.06M -16.3M -15.82M -15.47M -16.02M -16.82M -14.57M -10.7M -8.42M
Interest Income
2.08M 2.23M 2.43M 2.67M 2.8M 2.88M 3.03M 3.2M 3.22M 3.1M 2.89M 1.89M 776K 264K n/a 136K n/a n/a
Pretax Income
-15.03M -16.61M -17.59M -16.45M -18.01M -18.73M -17.02M -15.88M -15.81M -14.96M -13.41M -14.06M -14.69M -15.76M -16.69M -14.5M -10.71M -8.41M
Net Income
-15.03M -16.61M -17.59M -16.45M -18.01M -18.73M -17.02M -15.88M -15.81M -14.96M -13.41M -14.06M -14.69M -15.76M -16.69M -14.5M -10.71M -8.41M
Selling & General & Admin
6.7M 7.31M 7.16M 6.81M 8.35M 8.68M 7.54M 7.08M 7.1M 7.18M 6.72M 6.25M 6.62M 6.36M 6.92M 6.32M 4.32M 3.58M
Research & Development
10.39M 11.54M 12.82M 12.29M 12.44M 12.93M 12.47M 12M 11.91M 10.88M 9.59M 9.57M 8.86M 9.66M 9.89M 8.24M 6.38M 4.83M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
17.1M 18.84M 19.98M 19.1M 20.79M 21.61M 20M 19.07M 19.02M 16.89M 16.3M 15.82M 15.47M 16.02M 16.82M 14.57M 10.4M 8.42M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 18.84M 19.98M 19.1M 20.79M 21.61M 20M 19.07M 19.02M 18.06M 16.3M 15.82M 15.47M 16.02M 16.82M 14.57M 10.7M 8.42M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
126.17M 124.92M 125.8M 125.45M 125.32M 125.14M 124.98M 124.93M 124.6M 124.59M 124.79M 124.65M 124.49M 124.42M 124.23M 124.11M 55.07M 33M
Shares Outstanding (Diluted)
126.17M 124.92M 125.8M 125.45M 125.32M 125.14M 124.98M 124.93M 124.6M 124.59M 124.79M 124.65M 124.49M 124.42M 124.23M 124.11M 55.07M 33M
EPS (Basic)
-0.12 -0.13 -0.14 -0.13 -0.14 -0.15 -0.14 -0.13 -0.13 -0.12 -0.11 -0.11 -0.12 -0.13 -0.13 -0.12 -0.19 -0.25
EPS (Diluted)
-0.12 -0.13 -0.14 -0.13 -0.14 -0.15 -0.14 -0.13 -0.13 -0.12 -0.11 -0.11 -0.12 -0.13 -0.13 -0.12 -0.19 -0.25
EBITDA
17.22M -17.22M -18.43M -17.49M -19.19M -20.02M -18.41M -17.59M -17.55M -16.89M -15.38M -14.96M -14.64M -15.22M -16.55M -14.29M -10.41M -7.79M
EBIT
n/a -18.84M -19.98M -19.1M -20.79M -21.61M -20M -19.07M -19.02M -14.96M -16.3M -15.82M -15.47M -16.02M -16.82M -14.57M -10.7M -8.42M
Depreciation & Amortization
-1.63M 1.63M 1.55M 1.61M 1.6M 1.59M 565K 1.48M 1.42M 1.17M 921K 860K 829K 806K 263K 277K 300K 627K